MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
24.42
+0.08
+0.33%
After Hours: 24.84 +0.42 +1.72% 19:58 09/09 EDT
OPEN
24.05
PREV CLOSE
24.34
HIGH
24.68
LOW
23.89
VOLUME
1.11M
TURNOVER
--
52 WEEK HIGH
26.87
52 WEEK LOW
12.00
MARKET CAP
3.90B
P/E (TTM)
-59.8676
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADPT last week (0831-0904)?
Weekly Report · 2d ago
Adaptive Biotechnologies (ADPT) Rebound Keeps Fair Value In Focus
Simply Wall St · 3d ago
Adaptive Biotechnologies (ADPT) Stock Looks Fairly Valued At Today’s Price
Simply Wall St · 5d ago
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Barchart · 09/01 15:05
Weekly Report: what happened at ADPT last week (0824-0828)?
Weekly Report · 08/31 09:08
Adaptive Biotechnologies Director Makes Eye-Catching Insider Move
TipRanks · 08/29 02:02
Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?
Simply Wall St · 08/28 03:26
Adaptive Biotechnologies (ADPT) Gets a Buy from Piper Sandler
TipRanks · 08/24 14:05
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its technologies to read the genetic code of a patient's immune system. It operates through two segments, which include Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic testing service, offered to clinicians. Its Immune Medicine business focuses on immune-repertoire sequencing, target antigen discovery, data licensing and TCR-antigen prediction models in the identification, validation, development and adoption of products and services.

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.